Psychopathology in systemic lupus erythematosus. I. Psychiatric observations.
D000293:Adolescent; D000328:Adult; D000342:Affective Symptoms / Q000209:etiology; D001241:Aspirin / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001927:Brain Diseases / Q000209:etiology; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D003863:Depression / Q000209:etiology; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007406:Interview, Psychological; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D008297:Male; D001523:Mental Disorders / Q000209:etiology*; D008875:Middle Aged; D010919:Placebos; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000209:etiology; D013577:Syndrome
D010919:Placebos; D003520:Cyclophosphamide; D001379:Azathioprine; D001241:Aspirin; D011241:Prednisone